Psychedelic-based medicine isn’t big business yet, but it’s headed there. Fox Rothschild and Akerman stand out in the Am Law 100 for their early involvement.
'Moving Beyond the Counterculture of the '60s': Why Some Law Firms See Promise in Psychedelics
Leave a Reply